Cargando…
A Screen Using iPSC-Derived Hepatocytes Reveals NAD(+) as a Potential Treatment for mtDNA Depletion Syndrome
Patients with mtDNA depletion syndrome 3 (MTDPS3) often die as children from liver failure caused by severe reduction in mtDNA content. The identification of treatments has been impeded by an inability to culture and manipulate MTDPS3 primary hepatocytes. Here we generated DGUOK-deficient hepatocyte...
Autores principales: | Jing, Ran, Corbett, James L., Cai, Jun, Beeson, Gyda C., Beeson, Craig C., Chan, Sherine S., Dimmock, David P., Lazcares, Lynn, Geurts, Aron M., Lemasters, John J., Duncan, Stephen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289059/ https://www.ncbi.nlm.nih.gov/pubmed/30404003 http://dx.doi.org/10.1016/j.celrep.2018.10.036 |
Ejemplares similares
-
A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
por: Guo, Jingyi, et al.
Publicado: (2021) -
iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery
por: Corbett, James L., et al.
Publicado: (2019) -
Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells
por: Blaszkiewicz, Josef, et al.
Publicado: (2022) -
Ancient mtDNA Genetic Variants Modulate mtDNA Transcription and Replication
por: Suissa, Sarit, et al.
Publicado: (2009) -
Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019)